- Home
- UPB
UPB
UPSTREAM BIO INC
as 12-20-2024 4:00pm EST
Stocks
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 1.1B | IPO Year: | 2024 |
| Target Price: | $56.50 | AVG Volume (30 days): | 417.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -24.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.97 - $29.46 | Next Earning Date: | 02-14-2025 |
| Revenue: | $2,207,000 | Revenue Growth: | 82.10% |
| Revenue Growth (this year): | -6.51% | Revenue Growth (next year): | -21.71% |
Latest UPSTREAM BIO INC News
UPB Breaking Stock News: Dive into UPB Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Upstream Bio Appoints Allison Ambrose as General Counsel
GlobeNewswire
6 days ago
Upstream Bio Announces Addition to Russell 2000® Index
GlobeNewswire
a month ago
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
TipRanks
a month ago
Upstream Bio reports Q3 revenue $607,000 vs $621,000 last year
GlobeNewswire
a month ago
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
GuruFocus.com
2 months ago
Orbimed Advisors LLC Acquires New Stake in Upstream Bio Inc
GlobeNewswire
2 months ago
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
TipRanks
2 months ago
Opening Day: Another trio of biotech IPOs make Friday debut
Compare UPB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "UPB UPSTREAM BIO INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.